Coronary Artery Calcium Dispersion and Cause-Specific Mortality

Ramzi Dudum1, Zeina A Dardari2, David I Feldman3

  • 1Department of Cardiovascular Medicine, Stanford University, Stanford, California; Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland.

Insights

Coronary artery calcium (CAC) dispersion, indicated by more calcified vessels or diffuse patterns, significantly increases risks for all-cause, cardiovascular disease (CVD), and coronary heart disease (CHD) mortality.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Medical Imaging

Background:

  • Coronary artery calcium (CAC) scoring is crucial for assessing subclinical atherosclerosis and refining cardiovascular risk stratification.
  • Existing research suggests that specific CAC characteristics, such as vessel involvement, volume, and density, differentially influence risk.
  • The impact of CAC dispersion, defined by the number of calcified vessels or CAC phenotype, on cause-specific mortality requires further investigation.

Purpose of the Study:

  • To evaluate the association between CAC dispersion, encompassing the number of calcified vessels and CAC phenotype (diffuse vs. concentrated), and cause-specific mortality.
  • To determine if CAC dispersion provides incremental prognostic information beyond the overall CAC score.

Main Methods:

  • Retrospective analysis of the CAC Consortium cohort (n=28,147) with CAC > 0, excluding individuals with pre-existing coronary heart disease (CHD).
  • Calculation of CAC area, density, and phenotype using the index of diffusion.
  • Statistical assessment of the relationship between CAC characteristics and cause-specific mortality, controlling for overall CAC score.

Main Results:

  • Increasing numbers of calcified vessels (dispersion) showed a graded increase in all-cause, cardiovascular disease (CVD), and CHD-specific mortality.
  • A diffuse CAC phenotype, compared to a concentrated phenotype among those with multi-vessel involvement, was associated with higher CVD-specific mortality and trends toward higher all-cause and CHD-specific mortality.
  • Diffuse CAC was characterized by less dense calcifications, larger CAC area, and involvement of multiple coronary vessels.

Conclusions:

  • CAC dispersion, both in terms of the number of calcified vessels and the diffuse phenotype, is a significant independent predictor of increased all-cause, CVD, and CHD mortality.
  • These findings highlight the prognostic importance of evaluating the spatial distribution and pattern of coronary calcifications beyond the total CAC score.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
56
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
23
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
22
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22